Grey Market Premium (GMP) Significance in IPO Explained

Open any IPO related WhatsApp group a few days before a subscription window closes and you will find it: a number, quoted in rupees, that someone is calling the GMP. GMP today: 120. GMP strong at 300. GMP turned negative, stay away. These messages travel faster than the IPO prospectus itself, and they influence more retail investment decisions than any amount of fundamental analysis.

The Grey Market Premium is probably the most widely followed and least formally understood metric in India’s primary market. This article explains what it actually is, how it is formed, what it genuinely tells you, where it systematically misleads you, and how to use it without becoming dependent on it.

The grey market premium is the additional amount, expressed in rupees per share, at which IPO shares are being bought and sold in an unofficial parallel market before those shares are officially listed on the BSE or NSE. It is not a regulated price. It is not published by any exchange. It is not calculated by any algorithm. It is simply the price at which willing buyers and willing sellers in an informal network are transacting, and the difference between that price and the official IPO issue price is the GMP.

If an IPO has an issue price of Rs 500 per share and grey market buyers are willing to pay Rs 620 per share, the GMP is Rs 120. The expected listing price implied by this GMP would be Rs 620. If the GMP is negative, say the grey market is trading at Rs 460 when the issue price is Rs 500, the implied GMP is negative Rs 40, which signals that market participants expect the stock to list below its issue price.

How GMP Is Expressed and Interpreted

IPO Issue Price: ₹500 per share

GMP of +₹120: Grey market buyers pay ₹620. Implied listing price: ₹620. Implied gain: 24%.

GMP of +₹30:  Grey market buyers pay ₹530. Implied listing price: ₹530. Implied gain: 6%.

GMP of ₹0:     Grey market buyers pay ₹500. No premium. Flat listing expected.

GMP of –₹40:  Grey market buyers pay ₹460. Implied listing price: ₹460. Implies listing loss of 8%.

Note: The implied listing price is an expectation, not a guarantee.

Actual listing price is set by real market orders on listing day.

The grey market for IPO shares exists in a legal and regulatory no man’s land. It is not illegal under Indian law. But it is entirely unregulated. SEBI does not oversee it. The stock exchanges do not participate in it. There is no clearing corporation settling the transactions. There is no investor protection mechanism. There is no arbitration forum. Deals are made between individuals, often connected through networks of informal dealers or sub brokers, entirely on the basis of trust and reputation.

The market operates in a defined window: from the time an IPO is announced and its price band is disclosed, through the subscription period, and up to the listing date. Once the shares are officially listed and freely tradable on the exchange, the grey market for that IPO effectively ceases to exist. Its purpose is to provide a price signal and a trading mechanism during the period when official trading is not yet possible.

The participants in the grey market are a mix of investors who received IPO allotment and want to exit before listing, investors who did not receive allotment but want to buy shares at any available price, traders speculating on listing day outcomes, and the informal dealers who facilitate these transactions and earn a spread. The ecosystem is well established in cities like Mumbai, Ahmedabad, Rajkot, and Surat, where grey market dealing in IPO applications and shares has a multi decade history.

0 SEBI oversight on grey market transactions. None whatsoever.

~65% Accuracy rate of GMP predicting correct listing direction in 2025

₹0 Legal recourse available to you if a grey market deal defaults

“The grey market is where sentiment travels before logic arrives. It is a measure of excitement, not of value.”

 

The Three Types of Grey Market Transactions

Not all grey market activity is the same. There are three distinct types of transactions that take place in the grey market around any given IPO, each with a different structure and a different risk profile.

Type 1: The GMP Trade

The most common and widely tracked type is a direct trade in IPO shares at the grey market price. Here, a seller who has applied for the IPO and expects to receive allotment agrees to sell those shares at the current grey market price to a buyer who wants exposure to the IPO before it lists. The deal is contingent on the seller actually receiving allotment. If the seller is not allotted shares, the deal collapses and no money changes hands.

In this structure, the seller locks in a guaranteed price today, eliminating the risk that the listing price is lower than expected. If the GMP is Rs 120 and the seller agrees to sell at Rs 620, they receive Rs 620 per share on listing day regardless of whether the stock actually opens at Rs 600 or Rs 700. The buyer, meanwhile, is betting that the listing price will exceed Rs 620 and they will profit on the difference. Both sides are exchanging different forms of uncertainty for a mutually agreed price.

Type 2: The Kostak Rate

The Kostak rate is a fundamentally different structure. Here, a buyer pays a fixed amount for the seller’s entire IPO application, not for the shares themselves but for the application. This payment is made before allotment is confirmed. Crucially, the buyer pays the Kostak rate regardless of whether the seller receives allotment. If the seller is allotted shares, the buyer receives those shares. If the seller receives no allotment, the buyer still loses the Kostak amount they paid.

The Kostak rate reflects the probability weighted value of an application in a heavily oversubscribed IPO. In an IPO where retail allotment chances are one in forty, a Kostak payment is essentially a bet that the seller wins the lottery. If the GMP is very high and the Kostak rate is also high, buyers are paying a meaningful premium just for the chance to receive shares. For sellers, the Kostak structure locks in a certain return regardless of allotment outcome, which is attractive when oversubscription is extreme and the chance of receiving any shares is low.

Kostak Rate: A Worked Example

IPO Issue Price: ₹200 per share. Lot size: 75 shares.

Application value: 75 × ₹200 = ₹15,000

GMP: ₹80 per share. Implied listing: ₹280.

Kostak rate quoted: ₹1,800 per application

Seller’s perspective:

  Receives ₹1,800 upfront regardless of allotment outcome.

  If not allotted: kept ₹1,800 for doing nothing. Guaranteed profit.

  If allotted: buyer takes the 75 shares at ₹280 each.

  Seller misses any listing upside above ₹280 but has zero risk.

Buyer’s perspective:

  Paid ₹1,800 for a chance at 75 shares.

  If not allotted: lost ₹1,800 entirely.

  If allotted and stock lists at ₹280: gains (280–200)×75 – 1800 = ₹4,200.

  If stock lists at ₹230: gains (230–200)×75 – 1800 = –₹550. Loss.

Type 3: Subject to Sauda

Subject to Sauda is a conditional version of the Kostak structure. The buyer agrees to pay a fixed premium to the seller, but only if the seller actually receives an allotment. If no allotment is received, the deal is automatically cancelled and no money changes hands. This structure is more common than the full Kostak rate because it eliminates the risk for buyers who do not want to pay for applications that yield no shares.

The Subject to Sauda price sits between the Kostak rate and the full GMP implied gain. A seller choosing Subject to Sauda over a full Kostak accepts that they receive nothing if unallotted, but receives more per application if allotted than they would have under the Kostak structure. The buyer accepts the risk of receiving nothing, but limits their downside to the premium paid in exchange for the higher upside if allotment materialises.

Transaction Type	Payment Condition	Risk Profile
GMP Share Trade	Conditional on allotment. Buyer pays only if seller receives shares.	Seller locks in price. Buyer bets on listing price exceeding agreed level.
Kostak Rate	Unconditional. Buyer pays regardless of whether allotment is received.	Seller has guaranteed profit. Buyer may lose entire Kostak if no allotment.
Subject to Sauda	Conditional on allotment. Deal cancelled entirely if not allotted.	Seller gets nothing if unallotted but more than Kostak if allotted. Buyer has no payment risk but no shares if not allotted.

How the Grey Market Premium Is Formed

The GMP is not set by anyone in particular. It emerges from the interaction of supply and demand among participants in the grey market network. Several factors push it higher or lower during the days between IPO announcement and listing.

• Subscription data: as the IPO subscription window progresses and live data shows retail, NII, and QIB oversubscription climbing, grey market buyers become more willing to pay higher premiums. Strong QIB subscription data on Day 3 of an IPO often causes the GMP to jump sharply.

• Market conditions: when the broader market, measured by Nifty 50 or Sensex, is rising strongly in the days before listing, grey market optimism rises with it. A sharp market selloff in the same period frequently causes GMP to collapse even for well regarded companies.

• Company and sector sentiment: a company in a hot sector, say artificial intelligence, defence, or renewable energy, commands a higher GMP than a similarly priced company in a less fashionable industry, sometimes regardless of the underlying fundamentals.

• Peer performance: if similar companies have recently listed at strong premiums, grey market participants price upcoming IPOs with that reference point in mind.

• Manipulation: the grey market has no transparency obligations and no audit trail. Operators with large positions in either direction have an incentive to influence the GMP number that circulates on social media and financial platforms. Artificially inflated GMP generates retail excitement and applications, which benefits sellers who want to exit at a premium. This manipulation happens and is impossible to detect.

Where Retail Investors Follow GMP

Despite being an unregulated market with no official publisher, GMP data is widely available through several informal but consistently followed channels. The numbers on these platforms are self reported by dealers and aggregated from multiple sources. None of them carry any official guarantee of accuracy.

Platform Type	What It Shows	Reliability
IPO specific websites (IPO Watch, Chittorgarh, InvestorGain)	Real time GMP, Kostak, and Subject to Sauda rates for all active IPOs. Updated multiple times daily.	Moderate. Numbers sourced from dealer networks. Can vary across platforms for the same IPO.
Financial news platforms (Moneycontrol, Economic Times Markets)	GMP coverage for high profile IPOs. Generally reported as a range or median.	Moderate. Tends to be more conservative and lag the informal market by a few hours.
WhatsApp and Telegram groups	Fastest dissemination but most susceptible to manipulation. GMP is shared without source or verification.	Low to moderate. Treat as directional only, never as precise.
Brokerage app IPO sections	Some brokers display GMP as a supplementary data point alongside subscription figures.	Moderate. Usually sourced from the same dealer networks as websites.

Why the Same IPO Can Show Different GMP Numbers on Different Platforms

Because the grey market has no central clearing or reporting mechanism, the GMP number you see depends on which dealer network the platform sources from. A platform with contacts primarily in Gujarat may show a different GMP from one with contacts in Mumbai or Delhi.

During fast moving periods, the spread between the highest and lowest quoted GMP for the same IPO can exceed twenty percent of the quoted level. Always look at multiple sources and treat the midpoint as a rough estimate, not a precise figure.

How Reliable Is GMP as a Predictor of Listing Price?

This is the question that matters most for retail investors who encounter GMP data during an IPO window and want to know whether to act on it. The honest answer is that GMP has directional value but highly unreliable precision, and its track record has deteriorated as India’s primary market has become more crowded and sentiment driven.

Studies of GMP data from recent IPO seasons suggest that when GMP is significantly positive, the stock does tend to list at a gain more often than not, somewhere around 60 to 65 percent of the time in 2025. When GMP is negative, listing at or below issue price is even more likely. In that directional sense, GMP is not useless. A strongly positive GMP from multiple sources does capture something real about prevailing sentiment.

Where GMP consistently fails is in predicting the magnitude of listing gains. An IPO showing a GMP that implies a 30 percent gain does not reliably list at 30 percent. It may list at 10 percent or at 50 percent. The grey market is a thin, informal market with limited participants relative to the millions who will trade the stock on listing day. The price signals it generates reflect the views of a narrow, self selected group of market participants, not the full universe of investors whose orders will determine the actual opening price.

GMP Signal	What It Suggests	How Much to Weight It
Strongly positive (above 20% of issue price)	Market optimism is high. Listing gain probable.	Useful directional signal. Do not anchor to the specific number.
Moderately positive (5 to 20% of issue price)	Mild enthusiasm. Modest listing gain possible.	Take note but do not over-index. Outcome range is wide.
Flat or near zero	Market neutral. Listing near issue price expected.	Reasonable signal if consistent across multiple sources.
Negative	Market expects listing below issue price. Caution warranted.	The most reliable GMP signal. Negative GMP has historically been more accurate than positive.
Very high (above 50% of issue price)	Extreme excitement. Likely involves manipulation or thin grey market.	Treat with skepticism. Such levels are frequently not matched on listing day.
Collapsing GMP in final days	Sentiment shifting. Earlier optimism evaporating.	A falling GMP in the final 24 to 48 hours before listing is a meaningful caution signal.

When GMP Got It Very Wrong: The Cases That Matter

Looking at cases where GMP was significantly wrong is more instructive than looking at the cases where it was right. India’s IPO market in 2021 and 2022 produced several high profile examples of GMP failure that retail investors should know.

Paytm, which listed in November 2021, carried a grey market premium in the weeks before listing that implied the stock would open at a meaningful gain. Instead, it listed at a discount of approximately 27 percent to its issue price and continued falling for weeks. The GMP had reflected the excitement around India’s largest digital payments company going public, not the actual valuation concerns that institutional investors had already priced in. The divergence between grey market optimism and institutional scepticism was stark and the retail investors who relied on GMP as a listing signal bore the cost.

On the other side, several IPOs in 2022 and 2023 showed flat or mildly negative GMP in the days before listing and then went on to deliver double digit listing gains because the grey market had underestimated institutional demand. The thin nature of the grey market means it can miss structural demand that exists outside its participant network.

In 2025, the pattern of GMP divergence from actual listing outcomes became more common as the year progressed. With over 100 mainboard IPOs and the market absorbing a record volume of new listings, grey market participants became progressively less accurate at predicting the magnitude of listing movements. The direction remained weakly predictive. The magnitude became essentially noise.

The Manipulation Problem Is Real

Promoters, early investors, and large allottees have a direct financial interest in ensuring that the GMP for their IPO stays high during the subscription window. A high GMP generates retail FOMO, drives subscription numbers up, and makes the company look like a hot issue.

Dealers who hold large grey market positions in a specific direction can also move the quoted GMP significantly in that direction given the thin volumes involved. This is not a conspiracy theory. It is a well understood feature of an unregulated, non transparent market. Before acting on any GMP number, ask: who benefits if I believe this number?

Legal Status and Tax Treatment of Grey Market Transactions

Many retail investors are unclear about whether participating in the grey market is legal. The short answer is that it occupies a grey area, hence the name. The grey market for IPO shares is not explicitly prohibited by Indian law or by SEBI regulations. There is no statute that makes it a criminal activity. However, it is also not authorised, regulated, or protected. SEBI has repeatedly cautioned investors against participating in it without ever banning it outright.

The legal ambiguity creates practical problems. Because grey market deals are not recorded on any exchange, there is no clearing corporation to guarantee settlement. If a buyer pays a Kostak rate and the seller later refuses to hand over the shares, the buyer has no regulatory recourse. Disputes are resolved through informal mechanisms, which typically means either accepting the loss or escalating through the dealer network in ways that carry their own risks.

On the tax front, grey market profits are taxable as income under Indian law. Because transactions are cash settled and informal, they do not generate the kind of documented trail that standard market transactions produce. This creates a tax compliance risk that many participants quietly ignore. The income tax department has periodically focused on grey market activity, particularly in regions with high IPO participation, and required participants to demonstrate the source of unexplained income.

Legal Dimension	Current Position	Practical Implication
SEBI regulation	Not regulated. Grey market has no SEBI oversight.	No protection, no arbitration, no recourse if deal defaults.
Legality	Not explicitly illegal but not authorised.	Participation is at your own risk with no regulatory safety net.
Tax on profits	Taxable as income or capital gains depending on nature of transaction.	Must be declared in ITR. Many participants do not declare, creating compliance risk.
Settlement guarantee	None. Deals settled on trust between parties.	Counterparty default is a real risk with no formal remedy.
SEBI future plans	As of early 2026, SEBI is exploring a regulated pre-IPO platform to formalise this kind of trading with transparency and oversight.	A regulated version of the grey market may emerge within the next few years, which would change the landscape significantly.

How to Use GMP Without Being Led Astray by It

GMP is not something a retail investor needs to act on. But it is something a retail investor will inevitably encounter, and the healthier approach is to know how to read it rather than to ignore it entirely or follow it blindly. Here is a practical framework.

• Use GMP as one sentiment data point among several, not as a standalone reason to apply or avoid an IPO. The checklist before applying should still begin with the RHP, the use of proceeds, the valuation relative to peers, and the QIB subscription data. GMP comes after all of that.

• Pay more attention to GMP direction than magnitude. Whether the GMP is positive or negative is more reliable information than the specific rupee figure being quoted. A strongly negative GMP from multiple sources over several consecutive days is a genuine caution signal. A strongly positive GMP that appears suddenly on the final day of the subscription window should be treated with skepticism about potential manipulation.

• Watch GMP trends over the subscription window rather than any single data point. A GMP that starts at Rs 80, climbs to Rs 150 on Day 2, and then falls to Rs 60 on Day 3 is telling you something meaningful about shifting sentiment. A stable, gradually rising GMP from multiple sources over three days is a more credible signal than a single spike.

• Never participate in Kostak or Subject to Sauda transactions unless you fully understand the structure and accept that you have zero legal recourse if the counterparty defaults. These are speculative instruments operating entirely outside the regulated system. For most retail investors, the expected value of these transactions does not justify the operational and legal risk.

• Remember that the investors most likely to have a correct view of the IPO, namely the institutional investors who have conducted proper due diligence, are not participating in the grey market at all. The GMP reflects the views of a narrower, more speculative group. The QIB subscription data on Day 3 of the subscription window is a more reliable signal of sophisticated demand than any GMP figure.

The Grey Market Premium is a colourful and persistent feature of India’s primary market ecosystem. It exists because millions of investors want a price signal before the official one arrives, and an informal market has evolved to supply that signal. Understanding what GMP is, how it is formed, and what its limitations are makes you a better informed participant in every IPO you encounter.

Disclaimer: This article is for educational purposes only and does not constitute investment advice or an endorsement of grey market participation. Grey market transactions carry significant legal, financial, and counterparty risks and are not regulated by SEBI. Participating in Kostak or Subject to Sauda transactions is done entirely at the investor’s own risk with no regulatory protection. Tax on grey market profits must be declared in your ITR.